OR WAIT null SECS
August 26, 2021
Aptamer Group and Bio-Works Technologies are partnering up to develop a new affinity resin for improved purification and scale-up of gene therapy vectors.
CC Bio has raised £890,000 (US $1.2 million) in seed funding from CMS Ventures to accelerate the development of an innovative approach to infection treatment and prevention.
August 25, 2021
AGC Biologics has broken ground on a new multipurpose facility in Copenhagen, Denmark, that will increase capacity.
Todos Medical has completed validation of its cPass neutralizing antibody blood test to monitor COVID-19 immunity.
Lonza plans to establish drug product manufacturing capabilities at is site in Guangzhou, China, to produce clinical trial and commercial supply in the country.
August 20, 2021
Bristol Myers Squibb has exercised the option to in-license an immune-modulating drug candidate developed by Exscientia.
3P Innovation has won a Princess Royal Training Award for its Graduate Development Programme (GDP).
August 19, 2021
Curia plans to expand the site’s commercial capabilities with this move.
Corning’s new Ascent fixed bed reactor (FBR) system is an automated bioproduction platform designed to significantly improve yields and reduce bioproduction costs.
August 18, 2021
BlueAllele has been granted a US patent for its advanced gene-editing technology, PALIDON, which is compatible with existing gene editing nucleases and delivery systems.